PRKN and Parkinson disease: Including our cohorts, the meta-analysis revealed a significant 1.65-fold increased PD risk in single PRKN mutation carriers (95% CI: 1.36, 2.00; P = 3.69E-07; I2 = 0.0%, Phet = 0.594) (Fig. 2).